Impact of COVID-19 on young cancer patients and survivors
Impacts of Coronavirus Disease 2019 (COVID-19) Pandemic on Adolescent and Young Adult (AYA) Cancer Patients and Survivors
This study is trying to see how the COVID-19 pandemic has affected the mental, physical, and social well-being of young cancer patients and survivors aged 18 to 39.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 600 (estimated) |
| Ages | 18 Years to 39 Years |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT04551378 on ClinicalTrials.gov |
What this trial studies
This observational study examines how the COVID-19 pandemic has affected the psychological, financial, physical, and social well-being of adolescent and young adult (AYA) cancer patients and survivors. Participants, aged 18 to 39 who were diagnosed with cancer between 15 to 39 years old, will complete an online survey assessing their COVID-19 specific psychological distress, healthcare utilization, health behaviors, and quality of life. The study aims to identify associations between demographic factors and resilience with these outcomes, and may lead to targeted interventions to improve the well-being of this vulnerable population.
Who should consider this trial
Good fit: Ideal candidates are AYA cancer patients and survivors aged 18 to 39 who were diagnosed between the ages of 15 to 39 and have received treatment at MD Anderson Cancer Center.
Not a fit: Patients who are unable to complete questionnaires in English or those who visited MD Anderson for non-treatment related reasons may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved psychosocial health interventions for AYA cancer patients and survivors affected by the pandemic.
How similar studies have performed: While the specific focus on AYA cancer patients during the COVID-19 pandemic is novel, similar studies have shown success in understanding the psychosocial impacts of health crises on vulnerable populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * PATIENT COHORT INCLUSION: * Initial cancer diagnosis between the ages of 15 to 39 * Received any cancer treatment at MD Anderson Cancer Center with data available in the MD Anderson Cancer Center Tumor Registry * For questionnaire provision: confirmed alive at time of contact Exclusion Criteria: * PATIENT COHORT EXCLUSION: * Inability to complete questionnaires in English * Seen at MD Anderson for a second opinion or non-treatment related visit
Where this trial is running
Houston, Texas
- M D Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Michael E Roth, MD — M.D. Anderson Cancer Center
- Study coordinator: Michael E Roth, MD
- Email: MRoth1@mdanderson.org
- Phone: 713-792-7751
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.